Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
08/2005
08/25/2005US20050187255 Novel curcumin analogues and uses thereof
08/25/2005US20050187251 Substituted N-heterocycle derivatives and methods of their use
08/25/2005DE102004005318A1 Verfahren zur Herstellung von 2,5-Dimethylphenylessigsäure A process for the preparation of 2,5-dimethylphenylacetic acid
08/24/2005EP1565438A1 Antitumor benzoylsulfonamides
08/24/2005EP1565430A1 Biguanide and dihydrotriazine derivatives
08/24/2005EP1565429A2 Aryl ureido derivatives and their medical use
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/24/2005CN1659171A Specific cyclolignans for treating insulin-like growth factor-1 receptor dependent diseases
08/24/2005CN1658855A O-substituted hydroxyaryl derivatives
08/24/2005CN1216055C Paroxetine hydrochloride anhydrous compound and its preparation method and use
08/24/2005CN1216053C 2,2-disubstituted 1,3-dioxolanes as antitussive atents
08/24/2005CN1216044C Alkynes compound selective reduction
08/24/2005CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
08/23/2005US6933394 Catalyst for synthesizing alkylene carbonate
08/23/2005CA2469592C Hiv integrase inhibitors
08/23/2005CA2162761C Antineoplastic cyclolignan derivatives
08/18/2005WO2005075450A2 Spiro-benzodioxoles and their use as cb1 antagonists
08/18/2005WO2005075401A1 Method for producing 2,5-dimethylphenyl acetic acid
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005CA2553970A1 Spiro-benzodioxoles and their use as cb1 antagonists
08/17/2005EP1562574A1 2-oxo-ethanesulfonamide derivates
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/16/2005US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products
08/16/2005US6930131 Hetero or aromatic-alkyloxyalkylphenylsulfonamide or analogs or derivatives useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia
08/16/2005US6929896 Iodonium or sulfonium compounds as photosensitive acid donors in the preparation of colour filters or chemically amplified resists
08/16/2005CA2125075C Process for the preparation of propylene glycol carbonate
08/11/2005WO2005073213A2 Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2005000233A3 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2005US20050176994 Simultaneously or continuously reacting a sulfuric ester alkylating agent, an aromatic hydrocarbon preferably containing an electron withdrawing group and an electron donating group, and a maleic anhydride derivative.
08/11/2005US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/10/2005EP1561748A1 Malonic acid monoesters and process for producing the same
08/10/2005EP1560831A1 Novel amino-substituted dihydropyrimido [4,5-d] pyrimidin one derivatives, their manufacture and use as pharmaceutical agents
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653030A Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1651425A Preparation method of 2-methyl-2-aryl-1, 3-oxa amylcyclo compound
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/04/2005WO2005070915A1 1,3-benzodioxol-5-ylmethyl methyl sulfone and its derivatives, preparation method thereof and whitening composition containing the same
08/04/2005WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
08/04/2005WO2005070860A1 Bicyclo[3.3.1]nonanes and bicyclo[3.3.1]nonenes and their use as flavour or fragrance ingredient
08/04/2005WO2005058865A3 Assay for entactogens
08/04/2005WO2005000804A3 Substituted indoles and a process for preparing substituted indoles
08/04/2005US20050171363 Process for producing trifluoromethyl- substituted 2- alkoxyacetophenone derivatives
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders
08/03/2005EP1558624A1 Continuous process for the preparation of fructopyranose sulfamate derivatives
08/03/2005EP1558568A1 Nitroaniline-based alkylating agents and their use as prodrugs
08/03/2005CN1649861A Kinetics resolution method
08/03/2005CN1649834A Novel propionic acid derivative
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/02/2005US6924379 Using as catalyst a zinc-substituted polyoxometalate, Na12[WZn3(H2O)2(ZnW9O34)2].48H2O and a Lewis base for efficient chemical fixation of carbon dioxide with epoxides to form cyclic carbonates; high selectivity, catalyst can be reused
08/02/2005US6924263 Perfumes; coametics, cleaning compounds
07/2005
07/28/2005WO2005068415A1 Phenylalanine derivative
07/28/2005US20050165259 Cannabinoids
07/28/2005US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla
07/28/2005US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/28/2005US20050165012 Spiro-pentacyclic compounds
07/28/2005US20050164953 Beta-secretase inhibitors
07/27/2005EP1287004B1 Synthetic process for the manufacture of an ecteinascidin compound
07/27/2005CN1646478A 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
07/27/2005CN1646473A Novel curcumin analogues and uses thereof
07/27/2005CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles
07/26/2005CA2380864C Fungicidal compounds having a fluorovinyl- or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof
07/26/2005CA2234642C 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
07/26/2005CA2125073C Reactor and continuous process to be carried out therewith for the preparation of ethylene glycol carbonate and propylene glycol carbonate
07/21/2005WO2005065779A1 Calcitonin gene related peptide receptor antagonists
07/21/2005WO2005020911A3 Benzo[1, 3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the same
07/21/2005WO2004050609A8 Substituted ureas and carbamates
07/21/2005US20050159449 Cannabinoids
07/21/2005US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
07/21/2005CA2549330A1 Calcitonin gene related peptide receptor antagonists
07/20/2005EP1554263A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
07/20/2005EP1185493B1 Quinones for treatment of diseases
07/20/2005EP1108706B1 Catalytic synthesis of aldehydes by direct hydrogenation of carboxylic acids
07/20/2005CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642551A Inhibitors of histone deacetylase
07/20/2005CN1211386C Antitumoral analogue of Et-743
07/20/2005CN1211379C Process for synthesizing cyclic carbonate
07/20/2005CN1211367C Prostaglandin agonists and their use to treat bone disorders
07/19/2005USRE38761 Styryl compounds which inhibit EGF receptor protein tyrosine kinase
07/19/2005US6919480 A chemical intermediate process including perfluorination, deesterification, irradiating with ultraviolet light, pyrolyzing to form a compounds, use as starting monomer for making a fluoropolymers
07/19/2005US6919475 A chemical intermediate for use in positron emission tomography, radioactive fluoride compounds with long half life
07/19/2005US6919470 Aryl and heteroaryl sulfonates
07/19/2005US6919211 Solid support comprising amino acid sequences for sequencing, fingerprinting and mapping biological macromolecules; structure and function analysis
07/14/2005WO2005063665A1 Propofol analogs, process for their preparation, and methods of use
07/14/2005WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR
07/14/2005WO2005062811A2 Catalytic sulfoxide-promoted c-h oxidation, and regioselective preparation of allylic carboxylates
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 183